Editors: Atta-ur-Rahman, Iqbal Choudhary

Frontiers in Anti-Cancer Drug Discovery

Volume 1

eBook: US $44 Special Offer (PDF + Printed Copy): US $363
Printed Copy: US $341
Library License: US $176
ISSN: 2451-8395 (Print)
ISSN: 1879-6656 (Online)
ISBN: 978-1-60805-626-2 (Print)
ISBN: 978-1-60805-161-8 (Online)
Year of Publication: 2010
DOI: 10.2174/97816080516181100101

Introduction

Frontiers in Anti-Cancer Drug Discovery” is an eBook series devoted to publishing the latest and the most important advances in Anti-Cancer drug design and discovery. Eminent scientists write contributions on all areas of rational drug design and drug discovery including medicinal chemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships. The eBook series should prove to be of interest to all pharmaceutical scientists involved in research in Anti-Cancer drug design and discovery. Each volume is devoted to the major advances in Anti-Cancer drug design and discovery. The eBook series is essential reading to all scientists involved in drug design and discovery who wish to keep abreast of rapid and important developments in the field.

Indexed in: Book Citation Index, Science Edition, BIOSIS Previews, EMBASE, Chemical Abstracts, EBSCO, Ulrich's Periodicals Directory.

Foreword

- Pp. iii
John K. Buolamwini
Download Free

Preface

- Pp. i-ii (2)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free

Contributors

- Pp. iv-ix (6)
Atta-ur-Rahman, M. Iqbal Choudhary
Download Free

Targeting Ribonucleotide Reductase for Cancer Chemotherapy

- Pp. 1-30 (30)
Nuno M.F.S.A. Cerqueira, Pedro A. Fernandes, Maria J. Ramos
View Abstract

Thymidine Phosphorylase/Platelet-Derived Endothelial Cell Growth Factor as a Target for Capecitabine: From Biology to the Bedsid

- Pp. 31-54 (24)
Girolamo Ranieri, Aldo Maria Roccaro, Angelo Vacca, Domenico Ribatti
View Abstract

Inhibitors of the Plasminogen Activation System - Promising New Agents for Suppressing Breast Cancer Metastasis

- Pp. 55-78 (24)
Joel D.A. Tyndall, Michael J. Kelso, Marie Ranson
View Abstract

Histone Deacetylase Inhibitors in Cancer Therapy

- Pp. 79-115 (37)
Alfredo Budillon, Francesca Bruzzese, Elena Di Gennaro
View Abstract

Second Generation Abl Tyrosine Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone (Second Edition)

- Pp. 116-131 (16)
Shinya Kimura
View Abstract

Aurora Kinase Family: A New Target for Anticancer Drug

- Pp. 132-148 (17)
Teresa Macarulla, M. Elena Elez, Francisco Javier Ramos, Josep Tabernero
View Abstract

Molecularly Targeted Therapy in Breast Cancer: The Tyrosine Kinase Inhibitors

- Pp. 149-157 (9)
Zeina A. Nahleh
View Abstract

New Perspectives in the Treatment of Melanoma: Anti-Angiogenic and Anti-Lymphangiogenic Strategies

- Pp. 158-167 (10)
Caterina A.M. La Porta
View Abstract

Therapeutic Potential of Endogenous Angiogenesis Inhibitors for Cancer Therapy: Historical Perspective and Future Direction

- Pp. 168-193 (26)
Mohanraj Dhanabal, Natarajan Sethuraman
View Abstract

Calcium Signals in Endothelium and their Role in the Control of Angiogenesis

- Pp. 194-218 (25)
Luca Munaron
View Abstract

Novel Purine Nucleoside Analogues for Hematological Malignancies

- Pp. 219-240 (22)
Anna Korycka, Ewa Lech-Maranda, Tadeusz Robak
View Abstract

The Place of Somatostatin Analogs in the Diagnosis and Treatment of the Neuoroendocrine Glands Tumors

- Pp. 241-272 (32)
Gabriela Melen-Mucha, Hanna Lawnicka, Dorota Kierszniewska-Stepien, Jan Komorowski, Henryk Stepien
View Abstract

Bortezomib in the Treatment of Cancer

- Pp. 273-283 (11)
Aldo M. Roccaro, Angelo Vacca, Domenico Ribatti
View Abstract

Cetuximab: Its Use in Combination with Radiation Therapy and Chemotherapy in the Multimodality Treatment of Head and Neck Cancer

- Pp. 284-297 (14)
Timothy D. Wagner, Gary Y. Yang
View Abstract

Platinum-Based Anticancer Agents

- Pp. 298-339 (42)
Irena Kostova
View Abstract

c-Myc and Downstream Targets in the Pathogenesis and Treatment of Cancer

- Pp. 340-379 (40)
Sam Robson, Inga Pukonen, Sylvie Abouna, Stella Pelengaris, Michael Khan
View Abstract

Small Molecule Vascular Disrupting Agents: Potential New Drugs for Cancer Treatment, a 2009 Update

- Pp. 380-427 (48)
Sui Xiong Cai
View Abstract

Developments in Targeted Therapy of Advanced Gastrointestinal Stromal Tumors

- Pp. 428-448 (21)
Piotr Rutkowski, Malgorzata Symonides, Marcin Zdzienicki, Janusz A. Siedlecki
View Abstract

Therapeutic Transfer of DNA Encoding Adenoviral E1A†

- Pp. 449-464 (16)
Helmut Deissler, Bertram Opalka
View Abstract

Compositions for Treatment of Cancer and Inflammation

- Pp. 465-480 (16)
Shahar Lev-Ari, Dov Lichtenberg, Nadir Arber
View Abstract

The Androgen Receptor as Putative Therapeutic Target in Hormone-Refractory Prostate Cancer

- Pp. 481-496 (16)
Yukio Kageyama, Nobuhiko Hyochi, Kazunori Kihara, Hiroshi Sugiyama
View Abstract

Older and New Formulations of Cladribine: Pharmacology and Clinical Efficacy in Hematological Malignancies

- Pp. 497-524 (28)
Tadeusz Robak, Anna Korycka, Ewa Robak
View Abstract

Developments of New Compounds and New Strategies in the Field of Cytotoxic Nucleoside Analogues

- Pp. 525-540 (16)
Lars P. Jordheim, Charles Dumontet
View Abstract

PET in Anti-Cancer Drug Development and Therapy

- Pp. 541-551 (11)
Rakesh Kumar, Dhanpathi Halanaik, Saurabh Dahiya
View Abstract

The Anti-Cancer Charm of Flavonoids: A Cup-of-Tea Will Do You Good!

- Pp. 552-587 (36)
Amr Amin, Michael Buratovich
View Abstract

Prevention and Treatment of Regimen-Related Mucosal Toxicity

- Pp. 588-600 (13)
Joanne M. Bowen
View Abstract

Recent Patents on Bacterial Proteins as Potential Anticancer Agents

- Pp. 601-622 (22)
Arsenio M.Fialho, Ananda M.Chakrabarty
View Abstract

Recent Patents on Therapeutic Agents for Cancer

- Pp. 623-740 (118)
Xun Li, Yalin Li, Wenfang Xu
View Abstract

Review of Selected Patents for Cancer Therapy Targeting: Tumor Angiogenesis

- Pp. 741-757 (17)
Mark N. Kirstein, Arkadiusz Z. Dudek
View Abstract

Targeting Vesicle Trafficking in Cancer Therapeutics

- Pp. 758-776 (19)
Paul K. Wright
View Abstract

Author Index to Volume 1

- Pp. 778-779 (2)
Bentham Science Publishers
Download Free

RELATED BOOKS

.Biotechnology and Drug Development for Targeting Human Diseases.
.Enzymatic Targets for Drug Discovery Against Alzheimer
.Applied Computer-Aided Drug  Design: Models and Methods.
.Medicinal Plants, Phytomedicines and Traditional Herbal Remedies for Drug Discovery and Development against COVID-19.